1. Clinical evaluation of circulating microRNAs as potential biomarkers of hepatocellular carcinoma in patients with chronic HBV infection. (15th February 2015) Authors: Caviglia, G.P.; Abate, M.L.; Petrini, E.; Gaia, S.; Manzini, P.; Carucci, P.; Rizzetto, M.; Smedile, A. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy. Issue 1 (16th February 2017) Authors: Ibrahim Kamal Jouness, R.; Rosso, C.; Marietti, M.; Caviglia, G.P.; Nascè, A.; Campion, D.; Cantamessa, A.; Carucci, P.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.05.4 Y90-RADIOEMBOLIZATION VERSUS SORAFENIB IN LOCALLY ADVANCED HCC WITH INTRAHEPATIC NEOPLASTIC PORTAL VEIN THROMBOSIS: THE PIEDMONT-AOSTA VALLEY ONCOLOGY NETWORK EXPERIENCE. (1st October 2020) Authors: Martelletti, C.; Gesualdo, M.; Carucci, P.; Gaia, S.; Burlone, M.E.; Okolicsanyi, S.; Grosso, M.; Pirisi, M.; Tabone, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response. (March 2023) Authors: Foglia, B.; Cannito, S.; Sutti, S.; Nurcis, J.; Turato, C.; Maggiora, M.; Doto, F.; Rosso, C.; Carucci, P.; Gaia, S.; Biasiolo, A.; Pontisso, P.; Bugianesi, E.; Albano, E.; Parola, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Percutaneous microwave (MW) is superior to radiofrequency ablation (RFA) to induce complete response in cirrhotic patients with very early and early hepatocellular carcinoma (HCC). (February 2019) Authors: Mosso, E.; Ciruolo, M.; Vola, S.; Carucci, P.; Rolle, E.; Risso, A.; Migliore, E.; Saracco, G.M.; Gaia, S. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PH-0499 SABR as a treatment option for HCC patients: efficacy and toxicity profile. (August 2021) Authors: Carlevato, R.; Chiofalo, V.; Spinelli, L.; Giglioli, F.R.; Carucci, P.; Rolle, E.; Rizza, G.; Faletti, R.; Romagnoli, R.; Saracco, G.M.; Fonio, P.; Iorio, G.C.; Guarneri, A.S.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3). (February 2020) Authors: Caviglia, G.P.; Abate, M.L.; Ciruolo, M.; Carucci, P.; Olivero, A.; Rolle, E.; Rosso, C.; Younes, R.; Ciancio, A.; Smedile, A.; Saracco, G.M.; Bugianesi, E.; Gaia, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC). (10th February 2016) Authors: Di Costanzo, G.G.; D'Angelo, S.; Zolfino, T.; Lorusso, V.; Montesarchio, V.; de Stefano, G.; Sacco, R.; Attili, A.F.; Benedetti, A.; Sansonno, D.; Giannitrapani, L.; Buonadonna, A.; Giovanis, P.; Cabibbo, G.; De Vita, F.; Carucci, P.; Pirisi, M.; Moscovici, M.; Pisconti, S.; Daniele, B. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The Piedmont-Aosta Valley Oncology Network experience in locally advanced HCC with intrahepatic neoplastic portal vein thrombosis: Y90-radioembolization versus Sorafenib. (February 2020) Authors: Martelletti, C.; Gesualdo, M.; Carucci, P.; Gaia, S.; Burlone, M.; Okolicsanyi, S.; Grosso, M.; Pirisi, M.; Tabone, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗